William Rice
Amministratore Delegato presso APTOSE BIOSCIENCES INC.
Patrimonio netto: 39 691 $ in data 30/04/2024
Posizioni attive di William Rice
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| APTOSE BIOSCIENCES INC. | Comptroller/Controller/Auditor | 07/04/2022 | - |
| Amministratore Delegato | 28/10/2013 | - | |
| Presidente | 28/10/2013 | - | |
| Presidente | 28/10/2013 | - | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Presidente | 28/09/2010 | - |
| Direttore/Membro del Consiglio | 28/09/2010 | - | |
| Amministratore Delegato | 01/01/2003 | - | |
| Presidente | 01/01/2003 | - |
Storia della carriera di William Rice
Precedenti posizioni note di William Rice
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Direttore/Membro del Consiglio | 08/06/2015 | 01/01/2021 |
| Independent Dir/Board Member | 08/06/2015 | 01/01/2021 | |
| ACHILLION PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 17/08/1998 | 01/08/2003 |
| Amministratore Delegato | 17/08/1998 | 01/08/2003 | |
| Fondatore | 17/08/1998 | 01/08/2003 | |
| Presidente | 17/08/1998 | 01/08/2003 | |
| Frederick National Laboratory For Cancer Research | Corporate Officer/Principal | 01/01/1992 | 01/01/1998 |
| Emory University School of Medicine | Corporate Officer/Principal | 01/01/1989 | 01/01/1992 |
Formazione di William Rice
| Emory University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Canada | 3 |
Posizioni
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
| Frederick National Laboratory For Cancer Research |
- Borsa valori
- Insiders
- William Rice
- Esperienza
